Peroxisome Proliferator—Activated Receptor (PPAR)-αActivation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats
- 1 February 2001
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (2) , 411-417
- https://doi.org/10.2337/diabetes.50.2.411
Abstract
Peroxisome proliferator—activated receptor (PPAR)-α agonists lower circulating lipids, but the consequences for muscle lipid metabolism and insulin sensitivity are not clear. We investigated whether PPAR-α activation improves insulin sensitivity in insulin-resistant rats and compared the effects with PPAR-γ activation. Three-week high fat-fed male Wistar rats were untreated or treated with the specific PPAR-α agonist WY14643 or the PPAR-γ agonist pioglitazone (both 3 mg · kg-1 · day-1) for the last 2 weeks of high-fat feeding. Like pioglitazone, WY14643 lowered basal plasma levels of glucose, triglycerides (-16% vs. untreated), and leptin (-52%), and also muscle triglyceride (-34%) and total long-chain acyl-CoAs (LCACoAs) (-41%) (P < 0.05). In contrast to pioglitazone, WY14643 substantially reduced visceral fat weight and total liver triglyceride content (P < 0.01) without increasing body weight gain. WY14643 and pioglitazone similarly enhanced wholebody insulin sensitivity (clamp glucose infusion rate increased 35 and 37% and glucose disposal 22 and 15%, respectively, vs. untreated). Both agents enhanced insulin-mediated muscle glucose metabolic index (Rg9) and reduced muscle triglyceride and LCACoA accumulation (P < 0.05). Although pioglitazone had more potent effects than WY14643 on muscle insulin sensitization, this was associated with its greater effect to reduce muscle LCACoA accumulation. Overall insulin-mediated muscle Rg9 was inversely correlated with the content of LCACoAs (r = -0.74, P = 0.001) and with plasma triglyceride levels (r = -0.77, P < 0.001). We conclude that even though WY14643 and pioglitazone, representing PPAR-α and PPAR-γ activation, respectively, may alter muscle lipid supply by different mechanisms, both significantly improve muscle insulin action in the high fat—fed rat model of insulin resistance, and this effect is proportional to the degree to which they reduce muscle lipid accumulation.Keywords
This publication has 48 references indexed in Scilit:
- Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with PalmitateJournal of Biological Chemistry, 1999
- Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR Agonist) ActionEndocrinology, 1998
- Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoADiabetes, 1997
- Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feedingDiabetes, 1997
- Improved insulin sensitivity by bezafibrate in rats: relationship to fatty acid composition of skeletal-muscle triglyceridesDiabetes, 1997
- High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defectDiabetes, 1997
- Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemiaJournal of Cardiovascular Risk, 1996
- Growth hormone-induced insulin resistance and its relationship to lipid availability in the ratDiabetes, 1996
- Activation of Protein Kinase Cα Inhibits Signaling by Members of the Insulin Receptor FamilyJournal of Biological Chemistry, 1995
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963